Quick Answer: Korean cosmetic regulation combines business registration, product classification, ingredient and safety standards, packaging information, advertising controls and post-sale oversight. Functional cosmetics add the applicable examination or reporting route. Keep these layers separate: a registered responsible distributor, a lawful formula and an acceptable label answer different compliance questions, and each needs evidence tied to the actual product.
Read the framework in layers and check effective dates
Start with the Korean Cosmetics Act in force on 20 October 2026, then identify the Enforcement Decree, Enforcement Rule and MFDS notices relevant to the product. The Act establishes the main duties, while subordinate rules provide operational detail. Record the provision, version and effective date used for each decision rather than retaining an undated summary.
The law database can display provisions with future effective dates alongside current text. Review those dates before treating new wording as an existing obligation. A launch scheduled after this article’s review date needs a further check for provisions becoming effective before manufacture, import or sale. Separate the current assessment from a forward planning note.
This article explains a review structure for conventional cosmetics and imported finished products. Customised cosmetics, unusual delivery systems, products aimed at particular users or presentations close to medicines can raise additional questions. Define the scope before creating a checklist so the team can identify what the checklist does not yet cover.
| Layer | Main question | Record to retain |
|---|---|---|
| Business | Is the relevant operation registered and managed? | Entity, role and registration evidence |
| Product route | Is the product ordinary or functional? | Classification and applicable examination/report basis |
| Technical compliance | Does the actual formula meet local rules? | Composition review and quality evidence |
| Consumer presentation | Are packaging and claims lawful? | Approved Korean text and claim substantiation |
| Continuing oversight | Can issues and changes be controlled? | Batch, complaint and change records |
Distinguish the manufacturer, brand and responsible distributor
The manufacturer controls production and supplies accurate technical records. The brand controls its commercial proposition and must coordinate product names, intended uses and promotional content. The Korean responsible distributor manages the local quality and safety responsibilities attached to that registered operation. These roles may sit in related companies, but shared ownership does not make their evidence interchangeable.
Write a role matrix at the beginning of the project. For each file, identify its creator, reviewer, approver and retention location. Include confidential composition, specifications, test reports, artwork and filing records. Establish an escalation route when the local reviewer needs information that a supplier will disclose only under confidentiality terms.
A contract can allocate work, deadlines and access rights, but the parties should not assume it removes statutory duties. Ask the Korean adviser to reconcile the planned operating model with the applicable registration and management requirements. Verify the actual entity names against the pack and import records before treating the matrix as final.
Resolve ordinary and functional product routes
The MFDS functional cosmetics overview describes the examination or reporting route. Assess the claimed purpose, intended use and complete presentation against the Korean functional categories. A familiar overseas category is useful background, but does not determine the Korean outcome. Record why the proposed route fits the product.
The Enforcement Rule provisions for functional examination identify the submission framework and recognise the separate reporting route under Article 10 of the Rule. Examination and reporting are alternatives only where the applicable criteria support that outcome. A manufacturer’s statement that a formula is standard should lead to verification of the reporting conditions and product match.
Create a route worksheet containing the formula revision, functional claim, supporting evidence, intended applicant or holder and required next action. If examination is needed, map the evidence against the relevant requirements and identify any accepted omission or exemption precisely. Do not order a generic test package without first agreeing the actual data needs.
Ordinary cosmetic status should be recorded with its claims boundary. If marketing later adds a functional benefit or changes the use area, reopen classification before publication. Business registration, ingredient-list reporting and functional-product reporting should have separate entries in the compliance tracker, because completing one does not establish completion of the others.
| Record | What it supports | What still needs review |
|---|---|---|
| Business registration | The registered operation | Product formula and claims |
| Functional examination or report | The specific applicable product route | Batch quality and consumer presentation |
| Formula review | Composition for the defined use | Finished-product performance claims |
| Test result | The tested sample and conditions | Changes, other uses and legal classification |
| Approved artwork | The reviewed pack revision | Later online content and amendments |
Build a reproducible ingredient and safety assessment
Give the reviewer a quantitative formula with constituent composition for premixes, not just trade names. Include ingredient identity, function, finished-product contribution and material specifications. Preserve the link between the supplier’s blend composition and the finished formula calculation so a second reviewer can reproduce the result.
Check the current Korean restrictions and conditions applicable to the exact substance, concentration and use. The review should resolve naming ambiguity and include relevant impurities or material quality concerns. Do not import a concentration limit from another market without checking the Korean basis. Our Japanese ingredient review guide provides a useful comparison of review tasks, while the Korean conclusion needs its own authority.
Plan finished-product evidence around the formula, use and pack. Stability, microbiological quality, preservation and packaging compatibility can inform a proportionate quality assessment, depending on the product. State which sample and revision were tested, who performed the work and what the result actually demonstrates. Avoid turning a passed test into an unrestricted safety claim.
For unusual ingredients, unclear restrictions or vulnerable-user positioning, escalate the specific uncertainty before production. A useful question includes the substance identity, amount, proposed purpose and supporting documents. Sending a long ingredient list without identifying the unresolved issue slows the review and makes an assumed answer more likely.
Treat import quality and traceability as technical evidence
The responsible distributor duties under Rule Article 12 connect imported product records with batch testing and distribution. Establish the applicable inspection arrangement before release, including the legal basis for any exception relied on. Keep import quantities, batch identifiers, inspection outcomes and distribution records reconcilable.
Design a sample record set for one SKU before scaling the system. It should let the operator identify the approved specification, the batch tested, the result reviewed and the decision to release. If an outside laboratory performs testing, agree sample identification and how corrected reports are handled. A result with no traceable sample reference is difficult to use in an investigation.
Keep manufacturer quality records connected to the Korean import file. The OEM/ODM manufacturing handoff should provide accurate formula and batch information, while the local operator determines how that evidence supports its obligations. A certificate from a factory is one input to the review; its scope and any local acceptance conditions need to be understood.
| Workstream | Manufacturer contribution | Brand and Korean operator contribution |
|---|---|---|
| Formula | Composition, revisions and material data | Local screening and classification |
| Quality | Specifications, batch results and investigations | Applicable inspection and release decision |
| Packaging | Pack specifications and coding method | Korean particulars, readability and claims |
| Safety issue | Batch investigation and technical response | Local evaluation, reporting and market action |
| Change | Advance notice with supporting evidence | Impact assessment before implementation |
Review Korean labels as a complete consumer instruction
The current Article 10 packaging particulars provide the statutory starting point. Review product identity, business details, ingredients, quantity, batch code, use period, warnings and functional indication where applicable, together with the detailed rules and packaging exceptions. Do not reduce this task to translating an English INCI list.
Have a competent Korean reviewer approve the complete joined ingredient list and instructions. Compare them with the final composition and intended use. Review the primary pack, outer pack and any insert together so required information is present in the appropriate place and remains readable on the smallest commercial size.
Use revision control for artwork. Keep the approved Korean text, final print proof, code position and a representative finished pack photograph together. When a packaging supplier proposes a smaller label or a different finish, review readability again. A technically accurate label can fail its practical purpose if print contrast or size makes it difficult to read.
Check online content and product demonstrations against the approved claims. Distinguish cosmetic benefits from medicinal impressions and keep substantiation linked to the actual statement. Raw-material evidence, a finished-product test and consumer feedback support different conclusions; do not present them as equivalent proof of every claim.
Maintain a usable dossier and a change decision trail
A dossier should answer questions, not merely store files. Use a table of contents organised around classification, composition, quality, labels, claims, local records and continuing oversight. The product information file organisation guide can help structure the handoff, while Korean requirements and decisions should remain explicitly identified.
Define a change request that captures what changed, why, affected SKUs and batches, supporting evidence and the reviewer’s conclusion. Formula constituents, suppliers, site, process, pack, directions or claims can alter the assessment. Decide whether testing, filings, artwork or existing stock need attention before implementing the change.
Create a complaint record that links the consumer report to a product and batch wherever possible. Agree when the local operator and manufacturer will exchange information and who decides on distribution holds or other action. Review repeated signals across batches rather than closing each case in isolation. Keep the relevant safety information reporting process accessible to the people who receive complaints.
For a structured technical request, contact the project team with the product brief, dossier index and precise open questions. Obtain qualified local advice on the final Korean route. The strongest compliance record explains both the decision and its limits, so another reviewer can understand what evidence supported release.
Frequently asked questions
Is Korean business registration a product approval?
No. Registration concerns the operation. Product classification, functional examination or reporting where applicable, ingredients, quality and presentation require their own review.
Do all functional cosmetics undergo the same examination?
The framework provides examination and a reporting route for qualifying products. Verify the precise criteria and the match to the actual product rather than assuming a standard formula automatically qualifies.
Can a foreign compliance dossier be used?
It can supply useful evidence, but it needs a Korean gap assessment. Formula limits, names, claims, local records and the product route must be checked for Korea.
Who should approve Korean artwork?
The brand should coordinate with the Korean responsible operator and a competent Korean reviewer. Approval must cover the complete pack, final composition, required particulars and the actual consumer claims.
When should the assessment be reopened?
Reopen it when the formula, supplier, site, process, pack, use, claims or relevant law changes. Record the impact on tests, filings, labels and stock before implementation.
Last reviewed: 26 October 2026. General planning information, not product-specific legal or safety advice. Confirm current Korean requirements and the intended distribution route with a qualified local adviser before importing or selling.